Market Trends of Global Epilepsy Monitoring Devices Industry
This section covers the major market trends shaping the Epilepsy Monitoring Devices Market according to our research experts:
The Conventional Devices Segment is Expected to Hold a Major Market Share Over the Forecast Period
The conventional devices segment is expected to hold a significant share in the market owing to its safety and efficiency. Conventional devices refer to electroencephalogram (EEG) devices used for the continuous monitoring of patients.
Amid COVID-19, the demand for epilepsy monitoring devices was increasing as there was a higher prevalence of epilepsy among infected patients. For instance, according to the study titled "Epilepsy during the COVID19 pandemic lockdown: a US population survey" published in June 2021, 25% of people in the United States reported an increase in seizure cases during the pandemic period. Hence, such incidents boosted the demand for conventional devices for epilepsy monitoring during COVID-19 owing to their popularity and adoption within the patient population.
Additionally, conventional devices are widely used in hospitals and clinics for continuous monitoring purposes. Conventional devices provide a proper diagnosis to professionals about the type of seizure to prescribe the appropriate treatment. These factors can be attributed to the increasing demand for continuous, non-invasive monitoring of epilepsy.
Furthermore, in December 2021, iMediSync showcased its comprehensive EEG solution (hardware + software + remote telehealth solution) iSyncWave to perform brain mental health screening and predictive analysis of potential mental conditions in just 10 minutes. The presence of such advanced products in the market also contributes to the growth of the segment.
Thus, owing to the abovementioned factors, the market segment is expected to project growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period
The high incidences of neurological disorders, especially epilepsy, and a large number of end-users in the United States are the major factors for the growth of epilepsy monitoring devices in this region.
According to the article titled "Epidemiology of status epilepticus in the United States: A systematic review" published in November 2020, the incidence of all status epilepticus in patients of all ages in the United States ranged from 18.3 to 41 per 100,000 people per year. Such a high burden of epilepsy has contributed to the increase in the demand for epilepsy monitoring devices to provide proper treatment to patients.
Furthermore, the presence of the major market players in this region and their spending extensively on research and development of new products is also expected to boost the growth of the market in this region. For instance, in January 2021, BioSerenity received 510(k) clearance for its electroencephalography (EEG) wearable device system from the United States Food and Drug Administration (FDA). This clearance includes BioSerenity's NeuronauteEEG system and IceCap EEG wearable device, which are intended to allow physicians to remotely monitor and assess the electrical brain activity of people living with epilepsy.
Thus, owing to the abovementioned factors, the studied market is expected to show growth in the North American region.
